Instil Bio annual return on equity
2021
2022
2023
2024
2025
Instil Bio Return on Equity (ROE) Growth & History (TIL)
Instil Bio's return on equity was −50.39% for fiscal 2025.
View full Instil Bio company overviewInstil Bio annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −50.39% | −12.87 pp |
| 2024 | 2024-12-31 | −37.51% | +15.45 pp |
| 2023 | 2023-12-31 | −52.96% | −4.38 pp |
| 2022 | 2022-12-31 | −48.58% | +12.24 pp |
| 2021 | 2021-12-31 | −60.82% | — |
Instil Bio quarterly return on equity
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −3.94% | +11.53 pp |
| Q1 2026 | 2026-03-31 | −3.74% | +14.20 pp |
| Q4 2025 | 2025-12-31 | −6.99% | −0.11 pp |
| Q3 2025 | 2025-09-30 | −10.78% | +1.62 pp |
| Q2 2025 | 2025-06-30 | −15.47% | −8.03 pp |
| Q1 2025 | 2025-03-31 | −17.94% | −6.68 pp |
| Q4 2024 | 2024-12-31 | −6.88% | −1.26 pp |
| Q3 2024 | 2024-09-30 | −12.40% | +13.02 pp |
| Q2 2024 | 2024-06-30 | −7.44% | −1.30 pp |
| Q1 2024 | 2024-03-31 | −11.26% | +5.66 pp |
| Q4 2023 | 2023-12-31 | −5.62% | +8.29 pp |
| Q3 2023 | 2023-09-30 | −25.42% | −12.48 pp |
| Q2 2023 | 2023-06-30 | −6.14% | +6.06 pp |
| Q1 2023 | 2023-03-31 | −16.92% | −6.74 pp |
| Q4 2022 | 2022-12-31 | −13.91% | −4.34 pp |
| Q3 2022 | 2022-09-30 | −12.94% | −5.99 pp |
| Q2 2022 | 2022-06-30 | −12.20% | −6.77 pp |
| Q1 2022 | 2022-03-31 | −10.17% | −2.78 pp |
| Q4 2021 | 2021-12-31 | −9.57% | — |
| Q3 2021 | 2021-09-30 | −6.95% | — |
| Q2 2021 | 2021-06-30 | −5.43% | — |
| Q1 2021 | 2021-03-31 | −7.39% | — |
Instil Bio return on equity trends
Between the periods ended 2021-12-31 and 2025-12-31, Instil Bio's return on equity increased from −60.82% to −50.39%, a change of +10.43 percentage points. The latest reported quarter, Q2 2026, shows −3.94%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Instil Bio source filings ↗